Cargando…
Nalmefene in alcohol‐dependent patients with a high drinking risk: Randomized controlled trial
AIMS: Reducing alcohol consumption is one treatment approach for alcohol‐dependent patients. This study compared nalmefene 20 mg and 10 mg with placebo, combined with psychosocial support, in alcohol‐dependent Japanese patients with a high or very high drinking risk level (DRL). METHODS: This was a...
Autores principales: | Miyata, Hisatsugu, Takahashi, Masayoshi, Murai, Yoshiyuki, Tsuneyoshi, Kana, Hayashi, Takako, Meulien, Didier, Sørensen, Per, Higuchi, Susumu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899457/ https://www.ncbi.nlm.nih.gov/pubmed/31298784 http://dx.doi.org/10.1111/pcn.12914 |
Ejemplares similares
-
Long‐term safety and efficacy of nalmefene in Japanese patients with alcohol dependence
por: Higuchi, Susumu, et al.
Publicado: (2020) -
Response to ‘Nalmefene in alcohol‐dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption’
por: Higuchi, Susumu, et al.
Publicado: (2020) -
Drinking Levels and Profiles of Alcohol Addicted Rats Predict Response to Nalmefene
por: Foo, Jerome Clifford, et al.
Publicado: (2019) -
Nalmefene: a new approach to the treatment of alcohol dependence
por: Paille, François, et al.
Publicado: (2014) -
Clinical relevance of nalmefene versus placebo in alcohol treatment: Reduction in mortality risk
por: Roerecke, Michael, et al.
Publicado: (2015)